Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention
- PMID: 37193856
- DOI: 10.1038/s41569-023-00877-z
Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention
Abstract
Cardiovascular diseases (CVDs) are the leading causes of morbidity and mortality in individuals with type 2 diabetes mellitus (T2DM). Secular changes in CVD outcomes have occurred over the past few decades, mainly due to a decline in the incidence of ischaemic heart disease. The onset of T2DM at a young age (<40 years), leading to a greater number of life-years lost, has also become increasingly common. Researchers are now looking beyond established risk factors in patients with T2DM towards the role of ectopic fat and, potentially, haemodynamic abnormalities in mediating important outcomes (such as heart failure). T2DM confers a wide spectrum of risk and is not necessarily a CVD risk equivalent, indicating the importance of risk assessment strategies (such as global risk scoring, consideration of risk-enhancing factors and assessment of subclinical atherosclerosis) to inform treatment. Data from epidemiological studies and clinical trials demonstrate that successful control of multiple risk factors can reduce the risk of CVD events by ≥50%; however, only ≤20% of patients achieve targets for risk factor reduction (plasma lipid levels, blood pressure, glycaemic control, body weight and non-smoking status). Improvements in composite risk factor control with lifestyle management (including a greater emphasis on weight loss interventions) and evidence-based generic and novel pharmacological therapies are therefore needed when the risk of CVD is high.
© 2023. Springer Nature Limited.
Similar articles
-
Incidence of cardiovascular events and vascular interventions in patients with type 2 diabetes.Int J Cardiol. 2017 Dec 1;248:301-307. doi: 10.1016/j.ijcard.2017.07.081. Epub 2017 Jul 23. Int J Cardiol. 2017. PMID: 28802735
-
Intensive glycaemic control in type 2 diabetes mellitus: does it improve cardiovascular outcomes?Natl Med J India. 2011 Jan-Feb;24(1):21-7. Natl Med J India. 2011. PMID: 21608354 Review.
-
Association of BMI with cardiovascular disease incidence and mortality in patients with type 2 diabetes mellitus: A systematic review and dose-response meta-analysis of cohort studies.Nutr Metab Cardiovasc Dis. 2021 Jun 30;31(7):1976-1984. doi: 10.1016/j.numecd.2021.03.003. Epub 2021 Mar 19. Nutr Metab Cardiovasc Dis. 2021. PMID: 33965298
-
All-cause mortality and cardiovascular events in a Spanish nonagenarian cohort according to type 2 diabetes mellitus status and established cardiovascular disease.BMC Geriatr. 2022 Mar 18;22(1):224. doi: 10.1186/s12877-022-02893-z. BMC Geriatr. 2022. PMID: 35303825 Free PMC article.
-
Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study.J Am Heart Assoc. 2021 Apr 6;10(7):e016947. doi: 10.1161/JAHA.120.016947. Epub 2021 Mar 17. J Am Heart Assoc. 2021. PMID: 33728932 Free PMC article. Clinical Trial.
Cited by
-
Influence of Dulaglutide on Serum Biomarkers of Atherosclerotic Plaque Instability: An Interventional Analysis of Cytokine Profiles in Diabetic Subjects-A Pilot Study.Medicina (Kaunas). 2024 May 30;60(6):908. doi: 10.3390/medicina60060908. Medicina (Kaunas). 2024. PMID: 38929525 Free PMC article.
-
The conceptualisation of cardiometabolic disease policy model in the UK.BMC Health Serv Res. 2024 Sep 13;24(1):1060. doi: 10.1186/s12913-024-11559-y. BMC Health Serv Res. 2024. PMID: 39272116 Free PMC article.
-
The Relationship between the Ewing Test, Sudoscan Cardiovascular Autonomic Neuropathy Score and Cardiovascular Risk Score Calculated with SCORE2-Diabetes.Medicina (Kaunas). 2024 May 17;60(5):828. doi: 10.3390/medicina60050828. Medicina (Kaunas). 2024. PMID: 38793011 Free PMC article.
-
Association of constipation with all-cause mortality among individuals with type 2 diabetes: A retrospective cohort study.J Diabetes Investig. 2025 Mar;16(3):501-509. doi: 10.1111/jdi.14375. Epub 2024 Dec 24. J Diabetes Investig. 2025. PMID: 39718116 Free PMC article.
-
Association between atherogenic index of plasma and type 2 diabetic complications: a cross-sectional study.Front Endocrinol (Lausanne). 2025 Feb 4;16:1537303. doi: 10.3389/fendo.2025.1537303. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 39968299 Free PMC article.
References
-
- Blair, M. Diabetes mellitus review. Urol. Nurs. 36, 27–36 (2016). - PubMed
-
- American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care 43, S14–S31 (2020).
-
- International Diabetes Federation. IDF Diabetes Atlas 10th Edition https://diabetesatlas.org/data/en/ (2021).
-
- Carracher, A. M., Marathe, P. H. & Close, K. L. International diabetes federation 2017. J. Diabetes 10, 353–356 (2018). - PubMed
-
- Gregg, E. W., Sattar, N. & Ali, M. K. The changing face of diabetes complications. Lancet Diabetes Endocrinol. 4, 537–547 (2016). - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous